Minimising risks during routine ophthalmic examinations in the COVID-19 era

Until we have a vaccine and see a reduction of COVID-19 cases down to zero, we must adjust and take every precaution possibly to protect our staff, as well as our patients.

The ophthalmic implications of COVID-19: What we know so far

Emerging data on conjunctivitis cases in COVID-19 patients necessitate high levels of caution and a meticulous approach during the pandemic.

When daydreaming in clinic, think about night-time dry eye

Facing challenge of corneal infection management in operated eyes

October 17, 2019

Early identification, aggressive treatment critical; when to consider surgical intervention

Immune mechanisms in allergic eye disease

February 26, 2018

Ocular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.

Cellular therapy of the corneal stroma: Real approach or science fiction?

January 08, 2018

The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.